
Globally, prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall. This video shows Etoposide treated DU 145 prostate cancer cells undergoing programed cell death, apoptosis.
BioSpherix and Phase Holographic Imaging (PHI) have teamed up to support researchers in their ambition to grow and analyze cells in a cell-friendly environment, without cell disturbing factors like labels, stains and temperature fluctuations.
Learn more about cell friendly as well as fast and easy-to-use live-cell imaging tool.
Phase Holographic Imaging PHI AB
Scheelevägen 22
223 63 Lund
Sweden
info@phiab.se
support@phiab.se
VAT: SE556542781101
faktura@phiab.se
ISIN: | SE0005504636 |
LEI: | 549300JZR79QYESM6296 |
HoloMonitor® and HoloMetrics® are registered trademarks. Copyright © 2012-2019, Phase Holographic Imaging PHI AB.
Privacy policy